| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 84153 |
|
13 |
12 |
$0.00 |
| 85025 |
|
3,829 |
3,393 |
$0.00 |
| 82306 |
|
1,028 |
1,022 |
$0.00 |
| 81001 |
|
980 |
896 |
$0.00 |
| 82728 |
|
265 |
263 |
$0.00 |
| 90471 |
|
1,154 |
1,136 |
$0.00 |
| 99214 |
|
1,452 |
1,420 |
$0.00 |
| 85027 |
|
720 |
660 |
$0.00 |
| 83550 |
|
221 |
218 |
$0.00 |
| 80053 |
|
4,084 |
3,543 |
$0.00 |
| 84443 |
|
1,439 |
1,419 |
$0.00 |
| 1111F |
|
367 |
353 |
$0.00 |
| 82043 |
|
1,564 |
1,495 |
$0.00 |
| 82607 |
|
157 |
154 |
$0.00 |
| 83036 |
|
3,247 |
3,220 |
$0.00 |
| 86780 |
|
411 |
410 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
769 |
765 |
$0.00 |
| 36415 |
|
7,777 |
6,687 |
$0.00 |
| 86140 |
|
364 |
353 |
$0.00 |
| 98967 |
|
12 |
12 |
$0.00 |
| 86706 |
|
624 |
622 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
176 |
171 |
$0.00 |
| 80048 |
|
1,293 |
1,258 |
$0.00 |
| 87591 |
|
351 |
346 |
$0.00 |
| 99213 |
|
1,109 |
1,096 |
$0.00 |
| 83735 |
|
656 |
556 |
$0.00 |
| 85652 |
|
344 |
332 |
$0.00 |
| 3079F |
|
247 |
235 |
$0.00 |
| 3075F |
|
298 |
286 |
$0.00 |
| 3074F |
|
891 |
817 |
$0.00 |
| 87340 |
|
583 |
583 |
$0.00 |
| 87086 |
|
202 |
187 |
$0.00 |
| 85730 |
|
95 |
95 |
$0.00 |
| 3044F |
|
486 |
479 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
18 |
12 |
$0.00 |
| 86901 |
|
14 |
13 |
$0.00 |
| 90739 |
|
26 |
26 |
$0.00 |
| 90656 |
|
80 |
80 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
13 |
12 |
$0.00 |
| 90686 |
|
217 |
217 |
$0.00 |
| 99202 |
|
12 |
12 |
$0.00 |
| 92227 |
|
28 |
28 |
$0.00 |
| 3080F |
|
15 |
13 |
$0.00 |
| 82746 |
|
14 |
14 |
$0.00 |
| 86850 |
|
14 |
13 |
$0.00 |
| 99441 |
|
12 |
12 |
$0.00 |
| 90677 |
|
12 |
12 |
$0.00 |
| 99211 |
|
3,378 |
2,749 |
$0.00 |
| 80061 |
|
2,726 |
2,709 |
$0.00 |
| 97110 |
|
593 |
355 |
$0.00 |
| 82274 |
|
541 |
539 |
$0.00 |
| 82540 |
|
1,563 |
1,495 |
$0.00 |
| 90472 |
|
170 |
169 |
$0.00 |
| 86703 |
|
890 |
888 |
$0.00 |
| 99212 |
|
557 |
544 |
$0.00 |
| 86705 |
|
406 |
405 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
88 |
87 |
$0.00 |
| 85610 |
|
624 |
585 |
$0.00 |
| 92100 |
|
13 |
13 |
$0.00 |
| 81003 |
|
443 |
415 |
$0.00 |
| 86480 |
|
28 |
28 |
$0.00 |
| 99442 |
|
747 |
725 |
$0.00 |
| 87491 |
|
351 |
346 |
$0.00 |
| 96413 |
|
22 |
15 |
$0.00 |
| 84439 |
|
254 |
247 |
$0.00 |
| 3077F |
|
296 |
280 |
$0.00 |
| 3078F |
|
1,144 |
1,056 |
$0.00 |
| 77067 |
|
209 |
209 |
$0.00 |
| 83540 |
|
252 |
249 |
$0.00 |
| 3051F |
|
26 |
26 |
$0.00 |
| 82248 |
|
150 |
150 |
$0.00 |
| 80076 |
|
40 |
40 |
$0.00 |
| 90715 |
|
52 |
52 |
$0.00 |
| 93770 |
|
13 |
12 |
$0.00 |
| 85007 |
|
18 |
13 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
178 |
171 |
$0.00 |
| 84100 |
|
472 |
394 |
$0.00 |
| 82565 |
|
27 |
27 |
$0.00 |
| 86900 |
|
14 |
13 |
$0.00 |
| 99204 |
|
46 |
46 |
$0.00 |
| 3046F |
|
13 |
13 |
$0.00 |
| 90750 |
|
39 |
39 |
$0.00 |
| 92012 |
|
27 |
27 |
$0.00 |
| 93005 |
|
13 |
13 |
$0.00 |
| 90661 |
|
13 |
13 |
$0.00 |
| 82570 |
|
13 |
13 |
$0.00 |
| 91300 |
|
18 |
17 |
$0.00 |
| 77062 |
|
12 |
12 |
$0.00 |